Bifendate is a clinically effective medicine used to treat liver diseases and it’s bioactivity involves decreasing alanine aminotransferase (ALT) and aspartate aminotransferase (AST) secreted by hepatocytes in chronic hepatitis B [1] and attenuating hepatic steatosis [2]. This evidence concerns the gene GPT and chronic hepatitis B virus infection.